Product Information
ETRAVIRINE 200 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $10.7885 per EA under NDC 69452025517. Its NADAC has been published 29 times since Feb 4, 2026.
FDA first approved this application on Oct 2, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Bionpharma Inc.NDC
69452025517
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ETRAVIRINEApproval Type
Generic (ANDA)
FDA Application
ANDA219152FDA Approved
10/2/2025
TE Code
AB
On Market Since
1/1/2026
Pharmacological Classes
Price Statistics
The NADAC for ETRAVIRINE 200 MG TABLET has been published 29 times since Feb 4, 2026, and over the history we have for it it has declined 7.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.7885 per EA |
|---|---|
| All-time high | $11.7118 (Feb 11, 2026) |
| All-time low | $10.7885 (Aug 19, 2026) |
| 52-week high | $11.7118 |
| 52-week low | $10.7885 |
| Median price | $11.4115 |
| Average price | $11.4100 |
| Largest weekly change | -4.0% (Aug 19, 2026) |
| Weeks tracked | 29 |
| Tracking since | Feb 4, 2026 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ETRAVIRINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ETRAVIRINE 200 MG TABLET, manufactured by Bionpharma Inc., is $10.7885 per EA (NDC 69452025517), effective Aug 19, 2026.
How has the price of ETRAVIRINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for ETRAVIRINE 200 MG TABLET has declined 7.9%. It has been tracked across 29 weekly CMS publications since Feb 4, 2026.
What are the highest and lowest recorded NADAC prices for ETRAVIRINE 200 MG TABLET?
Since Feb 4, 2026, the NADAC for ETRAVIRINE 200 MG TABLET has ranged from a low of $10.7885 (Aug 19, 2026) to a high of $11.7118 (Feb 11, 2026), with a median of $11.4115 per EA.
Are there cheaper alternatives to ETRAVIRINE 200 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ETRAVIRINE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ETRAVIRINE 200 MG TABLET?
ETRAVIRINE 200 MG TABLET (NDC 69452025517) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.